FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17193511000001105: Rasilez 300mg tablets (Waymade Healthcare Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Jun 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
59734701000001115 Rasilez 300mg tablets (Waymade Healthcare Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
59734801000001112 Rasilez 300mg tablets (Waymade Healthcare Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rasilez 300mg tablets (Waymade Healthcare Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Is a Aliskiren 300mg tablets true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Is a Aliskiren 300mg tablets false Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Has specific active ingredient Aliskiren hemifumarate true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Is a Product containing precisely aliskiren fumarate 300 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Has active ingredient Aliskiren hemifumarate false Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Has specific active ingredient Aliskiren hemifumarate false Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Aliskiren false Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Is a Rasilez true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Has basis of strength substance Aliskiren true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rasilez 300mg tablets (Waymade Healthcare Plc) 28 tablet Has AMP True Rasilez 300mg tablets (Waymade Healthcare Plc) Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) 30 tablet Has AMP True Rasilez 300mg tablets (Waymade Healthcare Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start